MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

The research got the thrust after the Department of Biotechnology (DBT), Ministry of Science and Technology and Indian Space ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Living intelligence systems can sense, learn, adapt and evolve through the use of AI, advanced sensors and biotechnology, and ...

Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...

Bristol-Plymouth Regional Technical School sent seven students to the hospital after they experienced light-headedness and ...

Product sales rose 11%, led by 14% volume growth. Products including Repatha, Blincyto and Tezspire all posted at least double digit sales growth, the company said. For the current year, Amgen expects ...

MAIA Biotechnology (MAIA) announced updated data from its THIO-101 pivotal Phase 2 clinical trial evaluating its lead clinical candidate, THIO, ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, February 03, 2025. Let’s ...

CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks that nosedived in January, going from $42.98 to $32.75 on ...

The new sorghum varieties provide a climate-smart alternative grain for food science, breweries and dairy farmers ...